Phase II Study of Pemetrexed Plus Cisplatin in the Treatment of Patients With Extensive Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Cisplatin; Pemetrexed
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 02 Jun 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 02 Oct 2008 Status changed from discontinued to completed, as reported by ClinicalTrials.gov.
- 06 Feb 2008 Status change from recruiting to discontinued.